NAPOLI, CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.434
EU - Europa 1.412
AS - Asia 370
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.222
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.427
PL - Polonia 630
RU - Federazione Russa 235
IE - Irlanda 171
SE - Svezia 135
HK - Hong Kong 119
IT - Italia 95
CN - Cina 88
SG - Singapore 73
JO - Giordania 44
DE - Germania 42
FI - Finlandia 29
IN - India 23
GB - Regno Unito 21
CH - Svizzera 14
VN - Vietnam 13
BE - Belgio 12
ES - Italia 11
AT - Austria 7
CA - Canada 7
TR - Turchia 7
CI - Costa d'Avorio 5
UA - Ucraina 4
DK - Danimarca 2
NL - Olanda 2
EU - Europa 1
ID - Indonesia 1
IR - Iran 1
KR - Corea 1
NO - Norvegia 1
PT - Portogallo 1
Totale 3.222
Salva come PNG Salva come JPEG
Città #
Warsaw 628
Chandler 176
Dublin 171
Fairfield 163
Ashburn 124
Cambridge 95
Ann Arbor 83
Seattle 82
Houston 78
Hong Kong 74
Woodbridge 72
Wilmington 59
Singapore 55
Beijing 41
Princeton 35
Altamura 34
Bremen 31
Lawrence 31
Buffalo 29
Florence 29
Shanghai 26
Boston 21
Boardman 20
Kent 19
Medford 17
Mumbai 17
San Diego 17
Bern 14
New York 14
Santa Clara 12
Barcelona 11
Brussels 11
Council Bluffs 9
Falls Church 7
Helsinki 7
Jacksonville 7
Vienna 7
Dong Ket 6
Phoenix 6
West Jordan 6
Abidjan 5
Norwalk 5
Pune 5
Toronto 5
Redmond 4
Hillsboro 3
Izmir 3
Lappeenranta 3
Latina 3
London 3
Washington 3
Copenhagen 2
Los Angeles 2
Philadelphia 2
Radomsko 2
Sesto Fiorentino 2
Shenzhen 2
Surrey 2
Andover 1
Aprilia 1
Arezzo 1
Atlanta 1
Baotou 1
Bologna 1
Central District 1
Guangzhou 1
Hounslow 1
Kilburn 1
Kunming 1
Laurel 1
Lisbon 1
Lucca 1
Miami 1
Moscow 1
Naaldwijk 1
Nanjing 1
New Bedfont 1
Oggiono 1
Paceco 1
Palermo 1
Redwood City 1
Rui'an 1
Seoul 1
Tappahannock 1
Udine 1
Valdobbiadene 1
Totale 2.428
Salva come PNG Salva come JPEG
Nome #
RNA sequencing reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 254
The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response Pathways. 227
Thymidylate synthase expression and genotype have no major impact on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil 214
Druggable Targets in Pancreatic Adenocarcinoma 210
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 169
Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies 150
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies 118
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 116
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 109
Identification Of Pharmacogenomic Markers Of Clinical Efficacy In A Dose-Dense Therapy Regimen (R-Chop14) In Diffuse Large B Cell Lymphoma 95
D13Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 93
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer 90
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 86
Erratum: The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways (Oncology Research 25:9 (1441-1451) DOI: 10.3727/096504017X14926854178616) 76
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 71
Pharmacological modulation of protein kinase C for overcoming drug resistance in colorectal cancer. Preliminary results of in vitro studies. 69
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 69
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 69
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers 68
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 68
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 68
Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma 64
PNN and KCNQ1OT1 can predict the efficacy of adjuvant fluoropyrimidine-based chemotherapy in colorectal cancer patients 62
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphysms in primary colorectal cancer patients. 58
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 54
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 47
Thymidylate Synthase (TS) mRNA expression and TS gene promoter polymorphism in primary colorectal cancer (CRC) patients (PTS) receiving post-operative fluorouracil (5-FU)-based chemotherapy (CT) 46
Expression of thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) genes by polymerase chain reaction (PCR) in gastric cancer patients (PTS): preliminary results 45
Pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B cell lymphoma: preliminary results 45
Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines 39
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 37
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 36
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 35
Comparative genomic hybridization study of genetic changes associated with 5-fluorouracil resistance in HCT-8 colon cancer cell lines: correlations with the expression profiles 34
Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs 32
The role of thymidylate synthase (TS) expression in prognosis and outcome of 5-fluorouracil (5-FU)-based chemotherapy in patients (pts) with colorectal cancer (CC) 30
Molecular analysis of the FHIT gene in human sporadic colon cancers. 29
Quantitation of intratumoral thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression by the Polymerase Chain Reaction (PCR): marked variation among human colorectal cancer patients 29
Preliminary results of thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression analysis by polymerase chain reaction (PCR) in gastric cancer patients (PTS) 29
Marked variation thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression in human colorectal cancer 28
Targeting z-Crystallin by aspirin restores the sensitivity to cisplatin in resistant A2780 ovarian cancer cells 14
Totale 3.282
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.055
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.055
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020521 0 0 20 44 74 64 72 72 60 46 61 8
2020/2021364 34 40 1 49 19 31 34 21 38 45 29 23
2021/2022242 6 22 11 13 7 16 6 26 15 12 39 69
2022/2023818 59 128 40 80 63 140 105 49 104 3 18 29
2023/2024335 7 26 43 10 18 48 30 88 6 15 33 11
2024/2025389 68 189 132 0 0 0 0 0 0 0 0 0
Totale 3.282